Results 261 to 270 of about 90,332 (308)
Some of the next articles are maybe not open access.

Amyloidosis

Current Opinion in Rheumatology, 1996
Developments concerning amyloidosis associated with rheumatic diseases or often causing musculoskeletal symptoms are reviewed. The pathogenesis, clinical manifestations, diagnosis, and therapy of amyloid A, amyloid light-chain, and amyloid beta 2-microglobulin amyloidosis are discussed from the standpoint of a clinical rheumatologist.
C, Friman, T, Pettersson
openaire   +2 more sources

Amyloidosis

Current Opinion in Rheumatology, 1991
Amyloidosis is a disease involving the fibrillar deposition of proteins in a manner that uniformly leads to the presence of green birefringence on polarization microscopy after staining the involved tissues with Congo red. In the year summarized, a wide range of new information has accumulated about this disease.
A S, Cohen, L A, Jones
openaire   +2 more sources

Amyloidosis

Annual Review of Medicine, 2006
Amyloidosis is a clinical disorder caused by extracellular deposition of insoluble abnormal fibrils, derived from aggregation of misfolded, normally soluble, protein. About 23 different unrelated proteins are known to form amyloid fibrils in vivo, which share a pathognomonic structure although they are associated with clinically distinct conditions ...
openaire   +4 more sources

Amyloidosis

Orvosi Hetilap, 2010
Az amyloidosis különböző eredetű fibrilláris jellegű anyag extracelluláris felhalmozódása. Különböző szervekben lerakódva azok működését károsítja. A funkciókárosodásból adódnak a klinikai tünetek, az agyon kívül minden szerv érintett lehet, leggyakrabban a vese, a máj, a lép, a gastrointestinalis rendszer, az endokrin szervek, a bőr, a szív, a tüdő és
openaire   +3 more sources

Amyloidosis

Histopathology, 1994
Amyloidosis is a heterogeneous group of disorders characterized by extracellular deposition of abnormal protein fibrils which are dérived from different proteins in different forms of the disease. Asymptomatic amyloid deposition in a variety of tissues is a universal accompaniment of ageing, and clinical amyloidosis is not rare.
S Y, Tan, M B, Pepys
openaire   +2 more sources

Transplantation for amyloidosis

Current Opinion in Oncology, 2007
High-dose chemotherapy increasingly is being used for the management of patients with immunoglobulin light-chain amyloidosis. We describe nearly 300 patients who had treatment combining high-dose chemotherapy and stem cell transplantation at Mayo Clinic and review the recent literature.We review outcomes, engraftment data, and predictors of early ...
Morie A, Gertz   +4 more
openaire   +2 more sources

Friction Amyloidosis

International Journal of Dermatology, 1988
ABSTRACT: Three patients developed a peculiar pigmentation arising from prolonged mechanical friction with the skin due to the use of rough nylon towel or back scratcher for many years. Histochemical stains could not show the existence of amyloid in one of the cases, but amyloid deposition was identified in successive electron microscopic ...
C K, Wong, C S, Lin
openaire   +2 more sources

Amyloidosis in alkaptonuria

Journal of Inherited Metabolic Disease, 2015
AbstractAlkaptonuria (AKU) is an ultra‐rare inborn error of metabolism developed from the lack of homogentisic acid oxidase activity, causing homogentisic acid (HGA) accumulation that produces an HGA‐melanin ochronotic pigment, of hitherto unknown composition. Besides the accumulation of HGA, the potential role and presence of unidentified proteins has
MILLUCCI, LIA   +6 more
openaire   +4 more sources

[Amyloidosis].

Fortschritte der Medizin, 1976
Recent studies have clearly indicated that amyloid is a generic term which includes a number of different substances, all of which have a beta-pleated sheet structure and a characteristic fibrillar appearance in the electron microscope. The most common types are made of immunoglobulin light chain (AL) fragments in the primary and myeloma-associated ...
openaire   +2 more sources

[Amyloidosis and hepatic amyloidosis].

Nihon rinsho. Japanese journal of clinical medicine, 1993
The classification of amyloid and amyloidosis has undergone several revisions. The 1990 revision of the nomenclature at the 6th Internal Symposium on Amyloidosis in Oslo has been widely accepted and the basis for nomenclature and classification is the fibril protein making up the amyloid deposits.
T, Murakami, S, Yi
openaire   +1 more source

Home - About - Disclaimer - Privacy